Business Segments · Total assets of reportable segments
Cardiovascular — Total assets of reportable segments
Boston Scientific Cardiovascular — Total assets of reportable segments increased by 2.6% to $8.00B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 12.9%, from $7.08B to $8.00B.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ4 2025
Rolls up toOther Assets
How to read this metric
An increase suggests expansion of the segment's asset base, potentially indicating future growth capacity or recent acquisitions.
Detailed definition
This metric represents the total book value of assets directly employed by the cardiovascular segment to generate revenu...
Peer comparison
Comparable to 'Segment Assets' reported by diversified industrial and healthcare companies.
Metric ID:
bsx_segment_cardiovascular_total_assets_of_reportable_segmentsHistorical Data
8 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|
| Value | $2.82B | $5.21B | $5.99B | $7.08B | $7.41B | $7.50B | $7.80B | $8.00B |
| QoQ Change | — | +84.5% | +15.0% | +18.3% | +4.6% | +1.1% | +4.0% | +2.6% |
| YoY Change | — | +84.5% | +15.0% | +18.3% | — | — | — | +12.9% |
Range$2.82B – $8.00B
CAGR+81.4%
Avg YoY Growth+32.7%
Median YoY Growth+16.7%
Current Streak7+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's cardiovascular — total assets of reportable segments?
- Boston Scientific (BSX) reported cardiovascular — total assets of reportable segments of $8.00B in Q4 2025.
- How has Boston Scientific's cardiovascular — total assets of reportable segments changed year-over-year?
- Boston Scientific's cardiovascular — total assets of reportable segments increased by 12.9% year-over-year, from $7.08B to $8.00B.
- What does cardiovascular — total assets of reportable segments mean?
- The total value of assets dedicated to the cardiovascular business segment.